Alibaba Health Information Technology logo

Alibaba Health Information Technology(SEHK) 0241

Market CapHK$45.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1998)+137%
5 Year-73%
1 Year-52%
1 Month-4%
HK$2.88
+0.88%
+0.02Today
Alibaba Health Information Technology last closing stock price
MetricPriceDate
Last closeHKD 2.882026-10-14
Alibaba Health Information Technology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.13%HKD 2.822026-10-07
1 month-4%HKD 3.002026-09-14
3 month-17%HKD 3.472026-07-16
Year to date-42.97%HKD 5.052025-12-31
1 year-51.6%HKD 5.952025-10-14
3 year-41.58%HKD 4.932023-10-13
5 year-72.93%HKD 10.642021-10-15
Since inception+137.38%HKD 1.201998-08-24

Alibaba Health Information Technology Financials at a Glance

Market Cap

HK$45.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥49.55B

Net Income (TTM)

CN¥2.65B

EPS (TTM)

HK$0.13

P/E Ratio

21.67

Dividend

HK$0.07

Beta (Volatility)

-0.03 (Low)

Price

HK$2.88

Volume

65,346,005

Open

HK$2.85

Previous Close

HK$2.85

Daily Range

HK$2.81 - HK$2.89

52-Week Range

HK$2.75 - HK$7.91

Estimated Earnings Date

Dec 1, 2026

0241 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alibaba Health Information Technology

Alibaba Health Information Technology Limited is a leading player in the healthcare information services sector, focusing on pharmaceutical direct sales, e-commerce platforms, and digital healthcare services in Mainland China and Hong Kong. The company offers a diverse range of health-related products and services, leveraging technology to enhance healthcare accessibility and efficiency.

Products and Services
  • Pharmaceutical direct sales and e-commerce platforms
  • Healthcare services including medical consultations and checkups
  • Traditional Chinese medicine and various health-related products
Growth Outlook
  • Revenue increased to CNY 17.56 billion in the latest quarter
  • Net income rose to CNY 669.53 million, reflecting strong operational performance
  • Continued expansion in digital healthcare services is anticipated
Financial Highlights
  • Trailing twelve months (TTM) revenue of CNY 66.67 billion
  • Net profit margin of 5.65% indicates effective cost management
  • Cash and short-term investments total CNY 10.45 billion, ensuring liquidity
Alibaba Health Information Technology Limited operates in a rapidly evolving healthcare landscape, driven by increasing demand for digital health solutions. The company's robust revenue growth and profitability metrics highlight its operational efficiency and market position. With a strong cash position, the company is well-equipped to invest in future growth opportunities, particularly in the digital healthcare sector. The diverse product offerings and strategic partnerships further enhance its competitive edge, making it an attractive option for investors interested in the healthcare technology space.
AI Generated • Oct 14, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

1,394

CEO

Di Fan Shen

Website

www.alihealth.cn

Headquarters

Hong Kong, HK

0241 Financials

Key Financial Metrics (TTM)

Gross Margin

23.97%

Operating Margin

5.36%

Net Income Margin

5.65%

Return on Equity

10.95%

Return on Capital

10.28%

Return on Assets

8.41%

Earnings Yield

4.61%

Dividend Yield

2.41%

Payout Ratio

0.00%

Stock Overview

Market Cap

HK$45.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

16.13B

Volume

65.35M

Avg. Volume

78.99M

Financials (TTM)

Gross Profit

CN¥11.93B

Operating Income

CN¥2.58B

EBITDA

CN¥2.25B

Operating Cash Flow

CN¥2.14B

Capital Expenditure

CN¥28.00K

Free Cash Flow

CN¥2.14B

Cash & ST Invst.

CN¥10.45B

Total Debt

CN¥59.56M

Alibaba Health Information Technology Performance Analysis

Alibaba Health Information Technology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CNY 30,607,547,48322.6%
20242024-03-31CNY 29,508,638,139-3.6%
20252025-03-31CNY 33,034,837,91511.9%
20262026-03-31CNY 37,636,539,96513.9%
Alibaba Health Information Technology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-301.4%
Q42024-12-3114.4%
Q22025-09-30104.6%
Q42026-03-315.2%
Alibaba Health Information Technology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CNY 0.05N/A
20242024-03-31CNY 0.0751.5%
20252025-03-31CNY 0.1039.9%
20262026-03-31CNY 0.1337.1%
Alibaba Health Information Technology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-3059.3%
Q42024-12-31-14.2%
Q22025-09-30281.5%
Q42026-03-31-47.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

CN¥17.56B

+149.6%

Gross Profit

CN¥4.03B

+166.0%

Gross Margin

22.93%

N/A

Market Cap

HK$45.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$32.97M

N/A

Employees

1,394

N/A

Net Income

CN¥669.53M

+206.0%

EBITDA

CN¥325.89M

+51.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

CN¥10.45B

+9.4%

Total Debt

CN¥59.56M

-27.5%

Accounts Receivable

CN¥1.26B

+60.7%

Inventory

CN¥1.84B

+31.6%

Long Term Debt

CN¥30.08M

-37.3%

Short Term Debt

CN¥29.48M

-13.8%

Return on Assets

8.41%

N/A

Return on Invested Capital

10.24%

N/A

Free Cash Flow

CN¥679.19M

+731.5%

Operating Cash Flow

CN¥673.16M

+693.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
BACBank of America
$51.39-4.76%
NVDANvidia
$221.30-3.16%
CRWVCoreWeave
$65.78-15.46%
INTCIntel
$98.12-4.56%

Questions About 0241

What is the current price of Alibaba Health Information Technology?

Alibaba Health Information Technology is trading at HK$2.88 per share.

What is the 52-week range for Alibaba Health Information Technology?

Over the past 52 weeks, Alibaba Health Information Technology has traded between HK$2.75 and HK$7.91.

How much debt does Alibaba Health Information Technology have?

As of the most recent reporting period, Alibaba Health Information Technology reported total debt of CN¥67.82M.

How much cash does Alibaba Health Information Technology have on hand?

Alibaba Health Information Technology reported CN¥6.53B in cash and cash equivalents in its most recent financial results.

What is Alibaba Health Information Technology’s dividend yield?

Alibaba Health Information Technology currently has a dividend yield of 2.41%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services